Featured Suppliers:

Learn how & where to get products
that battle the causes of cancer.
That you can Beat Stage IV Cancer
w/out Chemotherapy or Radiation
Get the Answers You're Looking For.
Cancer disease

Sponsored Links


 
 

Cancer Program Benefits from 2009 Carnation Ball

Press Release  |  www.prlog.org | 8 hours 41 minutes ago

Cancer Program Benefits from 2009 Carnation Ball. Harold Mahony, Esq., chair of the board of directors of South Nassau Communities Hospital, and physician leaders Henry Partridge, MD, and Jerome Zisfein, MD, were honored at South Nassau’s 2009 Annual Carnation Ball.

http://www.prlog.org/10424939-cancer-program-benefits-from-2009-carnation-ball.html

Groups recommend less prevention for breast, cervical cancer screenings

News  |  www.fiercehealthcare.com | 11 hours 37 minutes ago

The American College of Obstetricians and Gynecologists has announced that it's recommending young women begin getting Pap smear tests at a later age than before, and less frequently than is... Read more...

http://www.fiercehealthcare.com/story/groups-recommend-less-prevent-less-breast-cervical-cancer-tests/2009-11-23?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FH0

Gundersen Lutheran Disagrees with New Breast Cancer Recommendations

Press Release  |  www.prnewswire.com | 12 hours 32 minutes ago

LA CROSSE, Wis., Nov. 23 /PRNewswire/ -- Women should continue to have annual mammograms starting at age 40 according to clinical breast radiologists at Gundersen Lutheran's Norma J. Vinger Center for Breast Care in La Crosse, Wis. An announcement this week by the U.S.

http://www.prnewswire.com/news-releases/gundersen-lutheran-disagrees-with-new-breast-cancer-recommendations-71653437.html

 

Mammography Guidelines Intensify Healthcare Reform Debate

News  |  www.medpagetoday.com | 14 hours 7 minutes ago

WASHINGTON -- The emotional debate over a federal panel's proposal to end routine mammograms for women in their 40s has reignited controversy over a contentious healthcare reform issue: comparative ef

http://www.medpagetoday.com/PublicHealthPolicy/Washington-Watch/17151

Seattle Genetics, Inc. and Agensys, Inc., an Affiliate of Astellas Pharma Inc., Expand Antibody-Drug Conjugate Collaboration; Will Pay $12 Million

News  |  www.biospace.com | 18 hours 12 minutes ago

BOTHELL, Wash. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Astellas, announced today an expansion of the companies’ antibody-drug conjugate (ADC) collaboration.

http://www.biospace.com/news_story.aspx?StoryID=163637&full=1

Interim Phase 2 Survival Data for PV-10 Shows Markedly Longer Overall and Disease Specific Survival for Subjects Responsive to PV-10 (Business Wire)

News  |  finance.yahoo.com | 18 hours 12 minutes ago

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT - News), a development-stage oncology and dermatology biopharmaceutical company, announced today

http://finance.yahoo.com/news/Interim-Phase-2-Survival-Data-bw-2902482908.html?x=0

At what age do cancer tests offer more risk than benefit?

News  |  www.ama-assn.org | 18 hours 12 minutes ago

Mr. Smith is an 86-year-old who comes to your office yearly for a physical exam. During his most recent visit he expresses concern you will recommend a colonoscopy. His last one was five years earlier and a 1 mm polyp was found.

http://www.ama-assn.org/amednews/2009/11/23/prca1123.htm

 

Results 1-10 of 47,053

Refine by Content Type:

  • Refined by: News  

Refine by Source:

Choose a source :

Close

100 Sources ...

Refine by Company:

Choose a company :

Close

88 Companies ...